(Q28212251)

0 references

Allen T Bruce

0 references

Hiroaki Ikeda

0 references

Robert D Schreiber

IMMUNOLOGY OF EXPERIMENTAL TUMORS.

0 references

language of work or name

English

0 references

publication date

November 2002

0 references

0 references

0 references

0 references

991-8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

https://api.crossref.org/works/10.1038%2FNI1102-991

1 reference

7 January 2021

Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Role of immunologic disturbance in human oncogenesis: some facts and fancies

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Effect of Neonatal Thymectomy on the Induction of Sarcomata in C57BL Mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Enhancing Effect of Thymectomy on Hepatotumorigenesis in Swiss Mice following Neonatal Injection of 20-Methylcholanthrene

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12-dimethylbenz(a)anthracene or urethan

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Neonatal thymectomy and non-viral mammary tumours in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

‘Nude’, a new hairless gene with pleiotropic effects in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Absence of Thymus in a Mouse Mutant

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Tumor Development after 3-Methylcholanthrene in Immunologically Deficient Athymic-Nude Mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Functional T cells in athymic nude mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

T-cell function and specificity in athymic mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Natural Cell-Mediated Immunity

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent Mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

DNA double-strand break repair

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Lymphocyte-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Decreased tumor surveillance in perforin-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Regulation of cutaneous malignancy by gammadelta T cells

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Occurrence of malignancy in immunodeficiency diseases. A literature review

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Posttransplant malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Cancer risk after renal transplantation in the nordic countries, 1964-1986

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Aids-related malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Cancer after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Malignant melanoma in organ allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Sarcomas in organ allograft recipients.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Solid tumors after heart transplantation: lethality of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Prognostic significance of histologic host response in cancer of the large bowel

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Prostatic carcinoma.Some morphological features affecting prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Lymphocytic infiltration and survival in rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Genetic instabilities in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Now you see it, now you don't!

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Human Mig chemokine: biochemical and functional characterization

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Natural Immunity: A T-Cell-Independent Pathway of Macrophage Activation, Defined in the scid Mouse

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

The roles of IFN gamma in protection against tumor development and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Spinning molecular immunology into successful immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Reciprocal activating interaction between natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021

Effect of interleukin 12 on tumor induction by 3-methylcholanthrene

1 reference

https://api.crossref.org/works/10.1038%2FNI1102-991

7 January 2021